The Pain Management Drugs Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of pain management drugs has seen substantial growth recently. The market, which was valued at $80.13 billion in 2024, is projected to increase to $84.51 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%.
The Pain Management Drugs market is forecasted to expand to a market size of $106.56 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.0%.
Download Your Free Sample of the 2025 Pain Management Drugs Market Report and Uncover Key Trends Now!The key drivers in the pain management drugs market are:
• Development and adoption of non-opioid alternatives and targeted therapies
• Advancements in precision medicine and psychological interventions
• Emphasis on reducing side effects of pain management drugs
• Implementation of value-based care models, expanded access programs, combination therapies.
The pain management drugs market covered in this report is segmented –
1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anesthetics, Anticonvulsants, Anti-Migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics
2) By Indication: Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain Or Strain, Bone Fracture, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The key trends in the pain management drugs market are:
• Value-based care models are becoming an important trend in pain management drugs.
• There is a surge in the utilization of expanded access programs.
• Combination therapies are surfacing as a prominent trend in managing pain effectively.
• The trend of developing innovative formulations and biosimilar pain drugs are shaping the future of the market.
Major companies in the pain management drugs market are:
• Novartis AG
• Eli Lilly and Company
• Abbott Laboratories
• Endo International plc
• Pfizer Inc.
• Merck & Co. Inc.
• Johnson & Johnson Services Inc.
• GlaxoSmithKline plc
• AbbVie Inc.
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca plc
• Bausch Health Companies Inc.
• Sanofi
• F. Hoffmann-La Roche Ltd.
• Boehringer Ingelheim
• Mallinckrodt Pharmaceuticals
• Daiichi Sankyo Company Limited
• Grünenthal GmbH
• Mundipharma International Limited
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• Zydus Cadila
• Lupin Pharmaceuticals Inc.
• Torrent Pharmaceuticals Ltd.
North America was the largest region in the pain management drugs market in 2024